Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tanaka

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Toxicological Sciences|November 1, 1992
[A 13-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 5 weeks]Y Nagashima, F Hisaoka, M Ide, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks]S Okazaki, S Nishimura, K Tamura, et al.
Schizophrenia Research|October 18, 1996
Preattentive and focal attentional processes in schizophrenia: a visual search studyS Mori, G Tanaka, Y Ayaka, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats]S Okazaki, E Yamazaki, K Tamura, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks]Y Nagashima, M Ide, H Akai, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 13-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 5 weeks]S Okazaki, E Yamazaki, K Tamura, et al.
Experimental Eye Research|September 1, 1991
Analysis of concurrent glucose consumption by the hexose monophosphate shunt, glycolysis, and the polyol pathway in the crystalline lensH M Cheng, J Xiong, G Tanaka, et al.
Angiogenesis|October 1, 2003
In vivo malignant phenotype of hst-1-transfected cells regulated by paracrine endothelial cell growth stimulation by HST-1M Aonuma, K Murakami, K Hirotani, et al.
Cancer Research|December 1, 1989
Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroidN G Tanaka, N Sakamoto, K Inoue, et al.
Oncology Reports|April 18, 2000
Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small cell lung cancerF Oshita, Y Kameda, K Nishio, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Toxicological Sciences|November 1, 1992
[A 13-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 5 weeks]Y Nagashima, F Hisaoka, M Ide, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks]S Okazaki, S Nishimura, K Tamura, et al.
Schizophrenia Research|October 18, 1996
Preattentive and focal attentional processes in schizophrenia: a visual search studyS Mori, G Tanaka, Y Ayaka, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats]S Okazaki, E Yamazaki, K Tamura, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks]Y Nagashima, M Ide, H Akai, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 13-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 5 weeks]S Okazaki, E Yamazaki, K Tamura, et al.
Experimental Eye Research|September 1, 1991
Analysis of concurrent glucose consumption by the hexose monophosphate shunt, glycolysis, and the polyol pathway in the crystalline lensH M Cheng, J Xiong, G Tanaka, et al.
Angiogenesis|October 1, 2003
In vivo malignant phenotype of hst-1-transfected cells regulated by paracrine endothelial cell growth stimulation by HST-1M Aonuma, K Murakami, K Hirotani, et al.
Cancer Research|December 1, 1989
Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroidN G Tanaka, N Sakamoto, K Inoue, et al.
Oncology Reports|April 18, 2000
Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small cell lung cancerF Oshita, Y Kameda, K Nishio, et al.
Pageof 9